iSonea to commercialise asthma monitoring devices – Electronics News

iSonea to commercialise asthma monitoring devices
Electronics News
ISONEA says it is focusing on the commercialisation of its over-the-counter asthma monitoring devices which will work with mobile health apps. iSonea is the joint effort of Israel-based iSonea and Australian company
iSonea accelerates commercialisation of asthma devices in US, in negotiations Proactive Investors Australia
iSonea ramps up product effortsAustralian Life Scientist
iSonea accelerates commercialisation of asthma devices in U.S., in Proactive Investors UK

all 5 news articles »

View full post on asthma – Google News

iSonea accelerates commercialisation of asthma devices in US, in negotiations … – Proactive Investors Australia

iSonea accelerates commercialisation of asthma devices in US, in negotiations
Proactive Investors Australia
They are focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma. iSonea is currently in negotiations with major strategic partners to accelerate commercialisation and cash flows of its next generation asthma products in

View full post on asthma – Google News

Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers

Condition:   Asthma
Interventions:   Drug: Seretide 250(8puffs) via Evohaler actuator;   Drug: Seretide 250 (8 puffs)/placebo via Volumatic spacer;   Drug: Seretide 250/placebo 8 puffs via Aerochamber Plus spacer;   Drug: Seretide 250/placebo via Synchro-Breathe
Sponsor:   University of Dundee
Completed – verified December 2009

View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days